Cargando…
Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR
BACKGROUND: Standard extracellular cardiovascular magnetic resonance (CMR) contrast agents (CA) do not provide differentiation between acute and older myocardial infarcts (MI). The purpose of this study was to develop a method for differentiation between acute and older myocardial infarct using myoc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867985/ https://www.ncbi.nlm.nih.gov/pubmed/20377842 http://dx.doi.org/10.1186/1532-429X-12-22 |
_version_ | 1782181019982495744 |
---|---|
author | Kirschner, Robert Toth, Levente Varga-Szemes, Akos Simor, Tamas Suranyi, Pal Kiss, Pal Ruzsics, Balazs Toth, Attila Baker, Robert Brott, Brigitta C Litovsky, Silvio Elgavish, Ada Elgavish, Gabriel A |
author_facet | Kirschner, Robert Toth, Levente Varga-Szemes, Akos Simor, Tamas Suranyi, Pal Kiss, Pal Ruzsics, Balazs Toth, Attila Baker, Robert Brott, Brigitta C Litovsky, Silvio Elgavish, Ada Elgavish, Gabriel A |
author_sort | Kirschner, Robert |
collection | PubMed |
description | BACKGROUND: Standard extracellular cardiovascular magnetic resonance (CMR) contrast agents (CA) do not provide differentiation between acute and older myocardial infarcts (MI). The purpose of this study was to develop a method for differentiation between acute and older myocardial infarct using myocardial late-enhancement (LE) CMR by a new, low molecular weight contrast agent. Dogs (n = 6) were studied in a closed-chest, reperfused, double myocardial infarct model. Myocardial infarcts were generated by occluding the Left Anterior Descending (LAD) coronary artery with an angioplasty balloon for 180 min, and four weeks later occluding the Left Circumflex (LCx) coronary artery for 180 min. LE images were obtained on day 3 and day 4 after second myocardial infarct, using Gd(DTPA) (standard extracellular contrast agent) and Gd(ABE-DTTA) (new, low molecular weight contrast agent), respectively. Triphenyltetrazolium chloride (TTC) histomorphometry validated existence and location of infarcts. Hematoxylin-eosin and Masson's trichrome staining provided histologic evaluation of infarcts. RESULTS: Gd(ABE-DTTA) or Gd(DTPA) highlighted the acute infarct, whereas the four-week old infarct was visualized by Gd(DTPA), but not by Gd(ABE-DTTA). With Gd(ABE-DTTA), the mean ± SD signal intensity enhancement (SIE) was 366 ± 166% and 24 ± 59% in the acute infarct and the four-week old infarct, respectively (P < 0.05). The latter did not differ significantly from signal intensity in healthy myocardium (P = NS). Gd(DTPA) produced signal intensity enhancements which were similar in acute (431 ± 124%) and four-week old infarcts (400 ± 124%, P = NS), and not statistically different from the Gd(ABE-DTTA)-induced SIE in acute infarct. The existence and localization of both infarcts were confirmed by triphenyltetrazolium chloride (TTC). Histologic evaluation demonstrated coagulation necrosis, inflammation, and multiple foci of calcification in the four day old infarct, while the late subacute infarct showed granulation tissue and early collagen deposition. CONCLUSIONS: Late enhancement CMR with separate administrations of standard extracellular contrast agent, Gd(DTPA), and the new low molecular weight contrast agent, Gd(ABE-DTTA), differentiates between acute and late subacute infarct in a reperfused, double infarct, canine model. |
format | Text |
id | pubmed-2867985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28679852010-05-12 Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR Kirschner, Robert Toth, Levente Varga-Szemes, Akos Simor, Tamas Suranyi, Pal Kiss, Pal Ruzsics, Balazs Toth, Attila Baker, Robert Brott, Brigitta C Litovsky, Silvio Elgavish, Ada Elgavish, Gabriel A J Cardiovasc Magn Reson Research BACKGROUND: Standard extracellular cardiovascular magnetic resonance (CMR) contrast agents (CA) do not provide differentiation between acute and older myocardial infarcts (MI). The purpose of this study was to develop a method for differentiation between acute and older myocardial infarct using myocardial late-enhancement (LE) CMR by a new, low molecular weight contrast agent. Dogs (n = 6) were studied in a closed-chest, reperfused, double myocardial infarct model. Myocardial infarcts were generated by occluding the Left Anterior Descending (LAD) coronary artery with an angioplasty balloon for 180 min, and four weeks later occluding the Left Circumflex (LCx) coronary artery for 180 min. LE images were obtained on day 3 and day 4 after second myocardial infarct, using Gd(DTPA) (standard extracellular contrast agent) and Gd(ABE-DTTA) (new, low molecular weight contrast agent), respectively. Triphenyltetrazolium chloride (TTC) histomorphometry validated existence and location of infarcts. Hematoxylin-eosin and Masson's trichrome staining provided histologic evaluation of infarcts. RESULTS: Gd(ABE-DTTA) or Gd(DTPA) highlighted the acute infarct, whereas the four-week old infarct was visualized by Gd(DTPA), but not by Gd(ABE-DTTA). With Gd(ABE-DTTA), the mean ± SD signal intensity enhancement (SIE) was 366 ± 166% and 24 ± 59% in the acute infarct and the four-week old infarct, respectively (P < 0.05). The latter did not differ significantly from signal intensity in healthy myocardium (P = NS). Gd(DTPA) produced signal intensity enhancements which were similar in acute (431 ± 124%) and four-week old infarcts (400 ± 124%, P = NS), and not statistically different from the Gd(ABE-DTTA)-induced SIE in acute infarct. The existence and localization of both infarcts were confirmed by triphenyltetrazolium chloride (TTC). Histologic evaluation demonstrated coagulation necrosis, inflammation, and multiple foci of calcification in the four day old infarct, while the late subacute infarct showed granulation tissue and early collagen deposition. CONCLUSIONS: Late enhancement CMR with separate administrations of standard extracellular contrast agent, Gd(DTPA), and the new low molecular weight contrast agent, Gd(ABE-DTTA), differentiates between acute and late subacute infarct in a reperfused, double infarct, canine model. BioMed Central 2010-04-07 /pmc/articles/PMC2867985/ /pubmed/20377842 http://dx.doi.org/10.1186/1532-429X-12-22 Text en Copyright ©2010 Kirschner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kirschner, Robert Toth, Levente Varga-Szemes, Akos Simor, Tamas Suranyi, Pal Kiss, Pal Ruzsics, Balazs Toth, Attila Baker, Robert Brott, Brigitta C Litovsky, Silvio Elgavish, Ada Elgavish, Gabriel A Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR |
title | Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR |
title_full | Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR |
title_fullStr | Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR |
title_full_unstemmed | Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR |
title_short | Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR |
title_sort | differentiation of acute and four-week old myocardial infarct with gd(abe-dtta)-enhanced cmr |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867985/ https://www.ncbi.nlm.nih.gov/pubmed/20377842 http://dx.doi.org/10.1186/1532-429X-12-22 |
work_keys_str_mv | AT kirschnerrobert differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT tothlevente differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT vargaszemesakos differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT simortamas differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT suranyipal differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT kisspal differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT ruzsicsbalazs differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT tothattila differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT bakerrobert differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT brottbrigittac differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT litovskysilvio differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT elgavishada differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr AT elgavishgabriela differentiationofacuteandfourweekoldmyocardialinfarctwithgdabedttaenhancedcmr |